Physiologically based pharmacokinetic modeling of ponatinib to describe drug–drug interactions in patients with cancer

被引：0
|
作者：
Tomoko O. Morita
Kazuhiko Hanada
机构：
[1] Meiji Pharmaceutical University,Department of Pharmacometrics and Pharmacokinetics
[2] National Cancer Hospital,Department of Clinical Research Support
来源：
Cancer Chemotherapy and Pharmacology | 2022年 / 90卷
关键词：
Interaction; Physiological pharmacokinetic models; Ponatinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：315 / 323
页数：8
相关论文
共 50 条
  • [1] Physiologically based pharmacokinetic modeling of ponatinib to describe drug-drug interactions in patients with cancer
    Morita, Tomoko O.
    Hanada, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (04) : 315 - 323
  • [2] Use of physiologically based pharmacokinetic modeling for assessment of drug-drug interactions
    Baneyx, Guillaume
    Fukushima, Yumi
    Parrott, Neil
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (05) : 681 - 693
  • [3] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug–Drug Interactions
    Ruben de Kanter
    Patricia N. Sidharta
    Stéphane Delahaye
    Carmela Gnerre
    Jerome Segrestaa
    Stephan Buchmann
    Christopher Kohl
    Alexander Treiber
    Clinical Pharmacokinetics, 2016, 55 : 369 - 380
  • [4] Physiologically Based Pharmacokinetic Modeling of Nilotinib for Drug-Drug Interactions, Pediatric Patients, and Pregnancy and Lactation
    Liu, Xiaomei I.
    Leong, Ruby
    Burckart, Gilbert J.
    Dallmann, Andre
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (03): : 323 - 333
  • [5] Physiologically-Based Pharmacokinetic Modeling of Macitentan: Prediction of Drug-Drug Interactions
    de Kanter, Ruben
    Sidharta, Patricia N.
    Delahaye, Stphane
    Gnerre, Carmela
    Segrestaa, Jerome
    Buchmann, Stephan
    Kohl, Christopher
    Treiber, Alexander
    CLINICAL PHARMACOKINETICS, 2016, 55 (03) : 369 - 380
  • [6] Prediction of Pharmacokinetic Drug-Drug Interactions Involving Anlotinib as a Victim by Using Physiologically Based Pharmacokinetic Modeling
    Bu, Fengjiao
    Cho, Yong-Soon
    He, Qingfeng
    Wang, Xiaowen
    Howlader, Saurav
    Kim, Dong-Hyun
    Zhu, Mingshe
    Shin, Jae Gook
    Xiang, Xiaoqiang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 4585 - 4600
  • [7] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex
    Conner, Todd M.
    Nikolian, Vahagn C.
    Georgoff, Patrick E.
    Pai, Manjunath P.
    Alam, Hasan B.
    Sun, Duxin
    Reed, Ronald C.
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 111 : 465 - 481
  • [8] Physiologically Based Pharmacokinetic Modeling as a Tool to Predict Drug Interactions for Antibody-Drug Conjugates
    Yuan Chen
    Divya Samineni
    Sophie Mukadam
    Harvey Wong
    Ben-Quan Shen
    Dan Lu
    Sandhya Girish
    Cornelis Hop
    Jin Yan Jin
    Chunze Li
    Clinical Pharmacokinetics, 2015, 54 : 81 - 93
  • [9] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 : 216 - 229
  • [10] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING IN PREDICTING DRUG-DRUG INTERACTIONS FOR TELMISARTAN IN HUMANS
    Kim, Jeong Ho
    Heo, Hyunjin
    Min, Jee Sun
    Kim, Doyun
    Bae, Soo Hyeon
    Bae, Soo Kyung
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S109 - S110
12345